ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,127.26
-0.20%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. iRadimed Corporation (IRMD)

  7. iRadimed Corporation (IRMD) Noticias

IRMD

iRadimed (IRMD)

iRadimed Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IRMD
FechaHoraFuenteTítuloSímboloCompañía
09/05/202408:16Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:IRMDiRadimed Corporation
08/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IRMDiRadimed Corporation
06/05/202415:15Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:IRMDiRadimed Corporation
02/05/202407:30GlobeNewswire Inc.IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per ShareNASDAQ:IRMDiRadimed Corporation
25/04/202415:05GlobeNewswire Inc.IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2ndNASDAQ:IRMDiRadimed Corporation
13/03/202415:30GlobeNewswire Inc.IRADIMED CORPORATION To Participate at the 36th Annual Roth ConferenceNASDAQ:IRMDiRadimed Corporation
01/03/202407:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IRMDiRadimed Corporation
13/02/202415:25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IRMDiRadimed Corporation
09/02/202414:54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IRMDiRadimed Corporation
08/02/202407:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRMDiRadimed Corporation
08/02/202407:05GlobeNewswire Inc.IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial ResultsNASDAQ:IRMDiRadimed Corporation
01/02/202415:05GlobeNewswire Inc.IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.NASDAQ:IRMDiRadimed Corporation
09/01/202407:30GlobeNewswire Inc.IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 RevenueNASDAQ:IRMDiRadimed Corporation
02/01/202415:30GlobeNewswire Inc.IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IRMDiRadimed Corporation
27/12/202317:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
13/12/202315:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IRMDiRadimed Corporation
12/12/202309:00GlobeNewswire Inc.IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per shareNASDAQ:IRMDiRadimed Corporation
30/11/202308:00GlobeNewswire Inc.IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by ForbesNASDAQ:IRMDiRadimed Corporation
03/11/202315:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRMDiRadimed Corporation
03/11/202307:00GlobeNewswire Inc.IRADIMED CORPORATION Announces Third Quarter 2023 Financial ResultsNASDAQ:IRMDiRadimed Corporation
26/10/202315:05GlobeNewswire Inc.IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rdNASDAQ:IRMDiRadimed Corporation
16/10/202316:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRMDiRadimed Corporation
06/09/202315:00GlobeNewswire Inc.IRADIMED CORPORATION to Participate at Upcoming Investor ConferencesNASDAQ:IRMDiRadimed Corporation
03/08/202307:00GlobeNewswire Inc.IRADIMED CORPORATION Announces Second Quarter 2023 Financial ResultsNASDAQ:IRMDiRadimed Corporation
27/07/202307:45GlobeNewswire Inc.IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rdNASDAQ:IRMDiRadimed Corporation
22/06/202315:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IRMDiRadimed Corporation
15/06/202315:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IRMDiRadimed Corporation
10/05/202316:45Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IRMDiRadimed Corporation
10/05/202307:30GlobeNewswire Inc.IRADIMED CORPORATION Named a 2023 Best Small Company in America by ForbesNASDAQ:IRMDiRadimed Corporation
04/05/202307:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IRMDiRadimed Corporation
 Showing the most relevant articles for your search:NASDAQ:IRMD

Su Consulta Reciente

AMEX
XLE
Energy Select Sector SPDR
NYSE
MRK
Merck
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
PM
XAUUSD
Gold vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
NYSE
AXP
American Express
NASDAQ
TSLA
Tesla
NYSE
MCD
McDonalds
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
FX
EURMXN
Euro vs MXN
NASDAQ
AAPL
Apple
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados